Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001683168-22-003055
Filing Date
2022-04-29
Accepted
2022-04-29 17:18:12
Documents
5
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT 1 cns_10ka1-123121.htm 10-K/A 183514
2 CERTIFICATION cns_ex3101.htm EX-31.1 3409
3 CERTIFICATION cns_ex3102.htm EX-31.2 3208
4 CERTIFICATION cns_ex3201.htm EX-32.1 3610
5 CERTIFICATION cns_ex3202.htm EX-32.2 3621
  Complete submission text file 0001683168-22-003055.txt   198393
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39126 | Film No.: 22877534
SIC: 2834 Pharmaceutical Preparations